Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Therapeutic Measures of Cathodal Transcranial Direct Current Stimulation (Tdcs) in Patients With Refractory Focal Epilepsy

NCT02866240 is registered in ClinicalTrials.gov with Neuroelectrics Corporation as lead sponsor.

NCT NCT02866240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Therapeutic Measures of Cathodal Transcranial Direct Current Stimulation (Tdcs) in Patients With Refractory Focal Epilepsy
Lead sponsor
Neuroelectrics Corporation
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2017
Completion date
December 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy